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Abstract: 
Kidney stone disease has become more common in children, but it remains non 
diagnosed in a significant proportion of patients, due to a lack of notable signs 
and symptoms. All children with colicky abdominal pain or microscopic 
hematuria should be examined thoroughly for urolithiasis. Patients’ histories in 
terms of family, medical, and drug and a thorough physical examination are 
required to be considered during diagnostic evaluation. Thereafter, diagnostic 
imaging methods should be aimed to detect the size, shape and location of 
calculi and also urinary tract anomalies. Ultrasound should be used as the 
initial imaging method to evaluate children with suspected nephrolithiasis. The 
noncontrast computerized tomography reserved for those in whom ultrasound 
is unable to diagnose stone. Increased water and fluid intake and a reduction of 
salt consumption are the common recommendation to those children with a 
history of kidney stones, though the rate of stone recurrence in children is 
unknown. Since metabolic disorders are the most frequent causes of stone in 
children, diagnostic evaluation should also target the detection of metabolic 
disorders including hypercalciuria, hyperoxaluria, hyperuricosuria and so on 
that may cause recurrent nephrolithiasis. Kidney stone is not a disease itself, 
but it is only a symptom. Therefore, its early diagnosis is mandatory for every 
child with the first stone event. In this article, we have summarized literature 
and emphasize that a few studies with acceptable quality are available on 
children with urolithiasis in Iran and the world that warrant future studies on 
this topic.  
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Introduction: 
Nephrolithiasis occurs following an interaction between environment and 
heredity traits 
[1]
. The incidence rate of this disease in children has increased 
[2, 
3]
. The worldwide prevalence of the disease has been reported 1-15% 
[3, 4, 5, 6, 7]
. 
Iran is in the "belt stone'' with a prevalence rate of about 2-3% 
[4, 8, 9]
. 
Urolithiasis as an important health issue is being recognized more commonly 
in the pediatric age group 
[10, 11, 12]
. However, the exact incidence rate of kidney 
stone disease in children is unknown 
[13, 14]
. In some areas of the world, the 
prevalence rates are significantly higher 
[15, 16]
. Different incidence rates 
reported in children with urolithiasis reflect the differences in geographic, 
genetic and socioeconomic backgrounds. 
[17, 18, 19]
. Urolithiasis appears in all 
pediatric age groups, but male predominance is observed 
[3]
. The strong male 
predominance seen in the adult population is less clear in children 
[5, 7, 20]
. Such 
an increase in the incidence of nephrolithiasis in children has some 
implications for health care 
[18]
. The characteristics of this disease in children 
are different than adults 
[5, 6, 18]
. Approximately, 75% to 85% of all kidney 
stones contain calcium salts composed of calcium oxalate and/or calcium 
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phosphate in the literature. The recurrence rate of 
nephrolithiasis in patients with kidney stones that are 
developed during childhood is poorly defined 
[4, 5, 21, 22]
. 
Within ten years, this disease usually recurs in more 
than 50% of patients 
[3]
.  
There are limited studies in pediatric patients. Also, 
a comprehensive review on the number of diseases that 
cause and affect kidney stones is restricted. Therefore, 
we reviewed the current literature on the diagnostic 
approach and dietary or pharmacological interventions 
aimed at decreasing the recurrence of kidney stones in 
children. Finally, we suggested carrying out metabolic 
workup in every child with nephrolithiasis, the need for 
sufficient attention to recurrence stones, and we 
highlighted areas in need of research in future. 
 
 
Clinical findings:  
The symptoms of urinary tract stones are often non-
specific, particularly in infants and young children 
[4]
. 
In addition, stones may remain asymptomatic during 
childhood and after that. The presentation of 
nephrolithiasis in children and adolescents differs from 
that in adults. The classic unilateral colicky flank pain 
occurs in only about 7% of patients 
[17]
.  
The most common symptom of urolithiasis is flank 
or abdominal pain; however, colicky pain in older 
children is also reported. Some studies reported “non-
specific” abdominal pain in infants that makes it 
difficult to be differentiated from acute abdomen. 
Sterile pyuria, or recurrent or urinary tract infections 
(UTIs) should raise the probability of the presence of 
urolithiasis. Gross hematuria may be present before 
other symptoms of urolithiasis 
[9, 11, 17]
. Main clinical 
presentation of renal stone is hematuria 
[5]
. However, 
its symptoms may be different based on the location of 
the stone 
[18]
. Stones located in the lower urinary tract 
may presented by dysuria, complete urine retention, 
enuresis, frequent voiding, and gross hematuria 
[5, 17]
. 
Also, the manipulation of genitals in younger children 
may be a first sign of urolithiasis in the urethra. A 
missed diagnosis may have serious consequences. 
Therefore, the underlying pathological condition is not 
often evident and may require patients’ history and 
following diagnostic work-up.  
UTI frequently is the presenting sign of urolithiasis 
in children 
[5, 11, 17]
. Urinary tract infection is an 
important disease, which can highlight the presence of 
renal stone diseases. In this respect, clinicians should 
take a precise history regarding urinary tract infection 
and ask for urine analysis and urine culture for all 
pediatric patients with urolithiasis 
[2, 9]
. Of the total of 
100 patients with urolithiasis, 54% referred with UTI 
[5]
. 
 
 
Underlying causes of renal stone: 
Children with urolithiasis are high-risk patients due 
to recurrent stone formation. The metabolic disorders 
are frequently associated disorders with urolithiasis in 
pediatric patients. Thereafter, the investigations for the 
diagnosis and detection of the etiology of stone, 
especially metabolic disorders are recommended. All 
patients with urolithiaisis should be evaluated 
regarding the possibility of metabolic abnormalities 
based on stone analysis 
[1, 5, 17]
.  
Through an awareness of serum and urine analyses, 
the stone composition is helpful for the diagnosis of 
metabolic disorders. Additional studies may be 
required notably in cases without available stone for 
analysis. Some authors believe that underlying 
metabolic disorders are not always indicated by stone 
analysis. Thus, the assessment of urine biochemistry 
has more useful results than stone analysis in children
 
[17]
.  
Obtaining a thorough medical history followed by a 
careful physical examination seems to be a lost art, 
though it is indispensable for an early and accurate 
diagnosis. It is important to obtain information 
regarding the family history, familial metabolic 
diseases, nutrition or specific diets, fluid intake, 
previous history of dehydration, medications, 
immobilization, gastrointestinal and neurologic 
diseases, and any mineral supplementation 
[17, 18, 21]
.  
Anatomic abnormalities such as ureteropelvic 
junction (UPJ) obstruction or ureterovesical junction 
(UVJ) obstruction, vesicoureteral reflux, and 
neurogenic bladder are found during the workup of 
nephrolithiasis in 11-24% of children 
[6,17,20]
.  
The anomalies of the urinary tract predisposing to 
urine stasis and urinary tract infection are special risk 
factors of stone formation. Approximately, 40% of 
children with urolithiasis have a positive family history 
of kidney stones 
[7, 18]
.  
According to another study, family history of 
urolithiasis is reported in 23% of patients 
[5]
. Depend 
on the geographical location of loving, hypercalciuria, 
hyperoxaluria, hypocitraturia or their combinations can 
be the most frequent metabolic disorders in children 
with nephrolithiasis 
[16, 17, 18]
. According to our study, 
68% hypocitraturia, 23% hypercalciuria, 11.4% 
hyperuricosuria, 8.4% hyperoxaluria, 8.9% cystinuria 
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and finally 1.2% proteinuria were observed in patients
 
[5]
. Hence, a systematic diagnostic examination of 
patients is necessary for every child who has 
experienced even a single kidney stone in order to 
prevent the recurrence of stone 
[1, 17]
. 
 
 
Laboratory Studies: 
Urinalysis should be performed in any child with 
nephrolithiasis. Microhematuria is the most common 
abnormality found in 60-95%. Pyuria is found in only 
20% of patients. Urinary leukocyte esterase and nitrites 
may be detected if there is an associated UTI. Blood 
cell counts and urine cultures should be performed, if 
the child is referred with the signs of infection 
[4, 11, 32]
. 
 
 
Risk Evaluation:  
Predisposing factors can be identified in up to 87% 
of children with urolithiasis and periodic stone disease 
occurs in 67% of pediatric patients 
[17]
. For these 
reasons, every child with the first stone event should 
have a complete evaluation of potential risk factors 
[5, 
23, 33]
. 
 
 
Metabolic Evaluation:  
The metabolic evaluation for urolithiasis is to 
identify children at the increased risk of the recurrent 
stone disease and specific metabolic diseases. If stones 
have been surgically removed or excreted from urine 
during spontaneous passage, analysis is helpful to 
guide the workup and determine the underlying 
pathologic processes 
[3, 17]
.  
Predisposing causes of urolithiasis can be 
recognized in more than 75% of children. Therefore, an 
early diagnostic examination is mandatory for every 
child with the first stone episode to prevent a delay in 
treatment that may lead to future complications 
[1,3]
. 
However, the detection of predisposing metabolic 
factors requires further examination. Metabolic factors 
are determined by the assessment of urinary solutes 
and naturally occurring inhibitors of crystal and stone 
formation such as citrate. Infection, obstruction, or 
stasis will be identified by the diagnostic evaluation 
outlined above.  
 
 
Serum Testing: 
Serum studies are typically not as informative as 
urine studies, but may provide useful information for a 
detailed evaluation of urine analysis results. Serum 
creatinine can identify renal insufficiency and is used 
to determine the expected excretion of creatinine in a 
given urine sample. The abnormality of serum 
potassium and magnesium can be associated with stone 
formation. For all patients, analyses for serum calcium, 
phosphorus, magnesium, uric acid, alkaline 
phosphatase, Vit D, bicarbonate, and creatinine should 
be performed. In other cases, further blood analyses for 
parathyroid hormone (PTH), vitamin B6 levels and 
plasma oxalate and, of course, molecular genetic 
testing may later be necessary 
[4, 17 ,18]
. 
 
 
Urinalysis: 
A complete analysis of a urine random sample is 
needed diagnostic evaluation in every acute stone 
episode. Hematuria, white blood cell (WBC) count, 
pH, density, crystals and urinary protein excretion can 
easily be determined. Since the pH of the urine is a 
major factor in the formation of different types of 
stones, a low urine pH may be associated with Ca, uric 
acid stones and a high pH may be associated with the 
possibility of infection stones or renal tubular acidosis 
(RTA).  
The elements of chemical urine analysis consist of 
creatinine, cystine, calcium, uric acid, oxalic acid, 
phosphate, magnesium and citrate. All crystals are seen 
in normal urine except cystine. The urine analysis is 
advisable for diagnostic evaluation and follow-up, and 
to assess the effect of the administration of alkali or to 
check the patient’s compliance with treatment now and 
future. The presence or absence of infection can be 
addressed by a urine culture 
[17, 33, 34]
.  
Since urinary components are influenced by dietary 
intake, 24h urine collections provide the best 
information about them and also about the daily intake 
of fluid. Urine should be collected for 24h to maintain 
the normal fluid intake and the normal dietary habits. 
The sampling should be avoided under parenteral 
infusions, during UTI, dehydration, diarrhea and fever. 
In children, or in situations where a 24h urine 
collection is difficult, a random urine measurement is 
accepted 
[32, 35, 36]
.  
Analysis should be deferred until UTI has been 
treated completely and at least four weeks after 
lithotripsy or resolution of the obstruction. The normal 
values for the excretion rates of solutes are affected by 
regional and cultural variability. Many children and 
adolescents with stones have more than one 
predisposing factor. When an inherited metabolic 
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disorder is suspected, urine samples from family 
members can be help to diagnosis. In patients with 
multiple stones at the onset, or those in whom there is 
active stone formation and no anatomical abnormalities 
have been determined, additional examinations can be 
helpful 
[3, 4]
.  
A spot urine sample is limited in its ability to 
evaluate metabolic risk, but it may provide useful 
information. A positive urine culture, urinary 
leukocytes, nitrites, and leukocyte esterase may suggest 
the presence of infection 
[4, 16, 17, 36]
. (table 1)
 [37]
 
In addition to spot urine and serum tests, a formal 
24-h urine collection is essential to determine the risk 
of stone formation. Because of variation in diet and 
fluid intake, results from 24h urine collections, ideally 
six weeks after that the patient achieves a stone-free 
status, should be used to guide treatment 
[17]
.  
 
Table 1. Random urine solute-to-creatinine ratio
 
by 
age  
 
Solute-to-
creatinine ratio 
Age Urinary 
Solute mg/ 
mg 
mmol/
mmol 
0.81 2.29 0-1 years 
Calcium 
0.56 1.58 1-2 years 
0.50 1.41 2-3 years 
0.41 1.16 3-5 years 
0.30 0.85 5-7 years 
0.25 0.71 7-10 years 
0.24 0.68 10-17 years 
0.29 0.37 < 6 months 
Oxalate 
0.20 0.26 6 months-2 years 
0.11 0.14 >2-5 years 
0.063 0.08 6-12 years 
0.031 0.04 > 18 years 
180 85 < 1 month 
Cystine 112 53 1-6 months 
38 18 > 6 months 
2.2 1.5 < 12 months 
Uric acid 
1.9 1.3 1-3 years 
1.5 1.0 3-5 years 
0.9 0.6 5-10 years 
0.6 0.4 < 10 years 
0.42 0.25 0-5 years 
Citrate 
0.25 0.15 > 5 years 
0.48 2.2 0-1 years 
Magnesiu
m 
0.37 1.7 1-2 years 
0.34 1.6 2-3 years 
0.29 1.3 3-5 years 
0.21 1.0 5-7 years 
0.18 0.9 7-10 years 
0.15 0.7 10-14 years 
0.13 0.6 14-17 years 
 
 
Specific Metabolic Findings: 
 
 
Hypercalciuria: 
Hypercalciuria is the most common cause of 
metabolic risk factor of renal stones in children, 
(representing up to 50%) 
[1, 5]
. 
In infants, it can be measured in random urine as 
calcium/creatinine ratio and in older children; it is 
measured in 24 hours urine collection. Defined as a 
urinary calcium excretion of more than 4 mg/kg/day, it 
is found in as many as up 10% of healthy children. In 
children, hypercalciuria can cause refractory 
haematuria, frequency-dysuria syndrome, UTI and 
abdominal and lumbar pain. In a majority of cases, the 
cause of hypercalciuria is idiopathic, both sporadic and 
familial. Alternatively, an increased number of vitamin 
D receptors may be responsible for hypercalciuria in 
certain patients. Other causes of hypercalciuria include 
distal RTA, medullary sponge kidney, UTI, and the use 
of medications such as adrenocorticotropic hormone 
(ACTH), theophylline, loop diuretics, and 
corticosteroids. Most children with hypercalciuria have 
normal serum calcium 
[38-41]
. 
A calcium-to-creatinine ratio can be derived from a 
single specimen and is often used as an initial 
screening test for hypercalciuria. If hypercalciuria is 
suspected based on a random spot sample. This should 
be confirmed with a 24-h urine collection. The infants 
with age below 12 month may have calcium-to-
creatinine ratio < 0.81 but infants with age 12- 24 
month may have ratio < 0/56 in normal condition 
[24, 36, 
42, 43]
. 
 
 
Hyperoxaluria: 
Oxalate is a metabolite excreted in urine. It is 
produced by metabolic pathways in body or comes 
from diet. It appears that 10-15% of urine oxalate is 
related to diet and restriction of diet oxalate affects this 
amount of urinary oxalate.  
Hyperoxaluria and consequently renal stones can be 
due to increased oxalate intake, decreased Ca intake, 
increased intestinal absorption of oxalate or inborn 
errors of metabolism. Inborn errors of metabolisms are 
the most severe causes of excessive urinary oxalate 
excretion named primary hyperoxaluria. 
Hyperoxaluria, may be detected in up to 20% of 
children with nephrolithiasis and most commonly is 
caused by idiopathic hyperoxaluria and mild elevations 
of urinary oxalate levels. Foods with high in oxalate 
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are beet and turnip greens, rhubarb, strawberries, star 
fruit, sweet potatoes, wheat bran, tea, cocoa, pepper, 
chocolate, parsley, spinach, beets, dill, nuts and citrus 
juices.  
The malabsorbed fatty acids displace luminal 
calcium from oxalate allowing increased absorption. In 
patients with hyperoxaluria, intestinal absorption of 
oxalate may be increased, due to either an increased 
intake of dietary oxalate or enteric reasons such as 
chronic inflammatory bowel diseases or a lack of 
colony count intestinal oxalate-degrading bacteria. 
Intestinal oxalate absorption is normal in patients with 
primary hyperoxaluria and would be significantly 
increased in those with dietary or enteric hyperoxaluria 
[1]
.  
Also, a stool analysis for evaluation of Oxalobacter 
formigenes, will give further evidence of the existence 
of a secondary reason for hyperoxaluria 
[18]
. 
 
 
Hyperuricosuria: 
Hyperuricosuria is common in children especially 
during infancy. Hyperuricosuria has been found in 2-
10% of children who are metabolically predisposed to 
kidney stone formation. Most patients with 
hyperuricosuria also have hypercalciuria; calcium 
oxalate urolithiasis may be coexistent. Hyperuricosuria 
may be familial or idiopathic and results in the 
overproduction of uric acid that occur secondary to 
inborn errors of metabolism, hemolysis, 
myeloproliferative disorders or a ketogenic diet 
[17]
.  
 
 
Cystinuria: 
Cystine stones consist approximately 2-8% of the 
stones in the pediatric population and result from 
elevated urinary excretion of cystine caused by an 
autosomal recessive disorder of tubular cell transport 
that are characteristically lifelong stone-formers. It is 
characterized by failure in the renal tubules to reabsorb 
four basic amino acids: cystine, ornithine, lysine and 
arginine. Cystine is poorly soluble at acidic pH, and at 
urine pH < 7.0 cystine it is precipitated and form stones 
[1, 18]
. 
 
 
Stone analysis:  
The analysis of the stone obtained after 
spontaneous stone passage or intervention is one of the 
most important diagnostic evaluation methods. Only 
one-third of all stones are composed of one single 
substance, and hence all components should be 
determined. The best methods of evaluation are 
infrared spectroscopy or X-ray diffraction. Chemical 
stone analysis is inappropriate, as it is prone to errors 
and is obsolete 
[4, 18]
. Recurrent stones should be 
analyzed, since the stone composition may change. 
With regard to treatment regimens, the stone 
components should be assessed 
[4]
. 
 
 
Imaging modality to diagnose renal stones 
in children: 
The imaging evaluation of nephrolithiasis in 
pediatric patients presents several unique issues. 
Initial diagnostic examinations have to uncover 
obstruction or stasis, infection, and metabolic 
abnormalities and profoundly rely on imaging of the 
urinary tract. With the availability of noninvasive 
imaging modalities, such as ultrasound, stones are 
increasingly being detected incidentally during the 
evaluation of nonspecific symptoms or unrelated 
problems. Individual clinical characteristics, type of 
stone, and questions to be addressed should be 
considered in making decisions regarding the best 
imaging modality. The imaging of the urinary tract has 
to be sufficiently thorough to rule out, assertively, 
stasis or obstruction related to a stone in urinary tract 
[11, 23, 24]
. The ultrasound is the best diagnostic imaging 
method in children with suspected nephrolithiasis. 
KUB (ureter bladder imaging), IVP (intravenous 
pyelography), and CT are other imaging modalities and 
reserving CT is for those with no symptomatic stones 
[4, 11]
.  
Although ultrasound is less sensitive than CT, 
ultrasound is usually a good initial choice and the most 
suitable method for the detection of urolithiasis in 
children because of radiation absence, no requirement 
of anesthesia, providing detailed anatomic information, 
cost–benefit issues, wide availability, detection of 
hydronephrosis and other anatomical disorders of the 
urinary tract. 
[2, 5, 25]
  
Ultrasound provides information about size, shape 
and location of stone in urinary tract, the grade of 
hydronephrosis, presence of obstruction due to stone 
and associated anomalies. However, ultrasonography is 
not as sensitive as CT for the detection of small stones 
or stones in the ureter. The measurement of stone size 
is less reproducible by ultrasound than CT; therefore, it 
may reduce its utility for active monitoring of 
metabolic stone formation over time. Nevertheless, as 
stones is smaller than 2 mm in diameter, it can be 
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visualized using ultrasonography (US), but the success 
of this imaging method depends on the observer’s 
skills 
[26,27]
. 
Ultrasonography will be sufficient in most 
circumstances; however, sometimes ultrasound fails to 
diagnose urinary tract stone in up to 40% of children. 
Some pitfalls in the renal ultrasonography occur with 
small stones, thin papillary or calyceal stones, ureteral 
stones and in neonates especially preterm infants. Also, 
Tamm–Horsfall protein (THP) deposits within the 
renal calyces may look like nephrocalcinosis. THP 
deposition, however, disappears within 2 weeks, and 
follow-up will show completely normal kidneys. 
Furthermore, the echogenicity of the renal cortex in 
neonates is increased; therefore, the detection of 
cortical nephrocalcinosis can be difficult 
[4, 11, 28, 29]
.  
Although KUB may detect stones, its sensitivity is 
low and lead to diagnosis in 30-60% cases 
[17, 25]
. KUB 
in combination with ultrasound helps clinicians to 
diagnose and follow renal stones. Many stones will 
contain elements of compound calcium within them 
and therefore are easily seen on x-ray. Some pitfalls of 
the KUB are small stones, ureteral stones, radiation 
exposure and the need to preparation 
[17, 25]
. 
Stones comprised of calcium oxalate or calcium 
phosphate are very radiodense and readily seen by both 
ultrasound and CT. Their appearance on imaging 
studies depends on the stone’s composition. Those 
composed of calcium oxalate or calcium phosphate 
creates a very dense image on x-ray and CT scans. 
Struvite and cystine stones are of intermediate 
radiodensity. Uric acid, xanthine, 2, 8 
dihydroxyadenine, and orotic acid stones are 
radiolucent by conventional radiography, but visible by 
ultrasonography or unenhanced CT 
[11, 18, 19, 30]
.  
Non-contrast spiral computed tomography (CT) 
scan is the gold standard for the diagnosis of 
nephrolithiasis, because it has an excellent 
visualization of all stones whether they are opaque or 
nonopaque. Except for indinavir stones, size and 
location of stones, it is rapid and nearly 100% sensitive 
and specific. CT scan provides detailed anatomic 
information and is sensitivity for very small stones. It 
is recommended to perform CT scan in children with 
refractory urolithiasis symptoms but without clear 
evidence of stone in KUB and ultrasonography. Some 
disadvantages of CT scan in children with 
nephrolithiasis include cumulative risk of radiation 
exposure associated with an increased risk of cancer, 
cost–benefit issues, need to anesthesia, availability and 
requirement for preparation. It is reported that 5% of 
stones in children cannot be diagnosed by CT scan. 
Nowadays, patients are less required to anesthesia and 
sedation and are less exposed to radiation with modern 
high speed CT scans. Long-term risks of radiation 
exposure in children are not completely understood. 
Although the risk of cancer from a single CT imaging 
performed for kidney stones is small, the cumulative 
risk is higher for those undergoing repeated studies. 
Additionally, the risk may be greater in children than in 
adults, because of a longer life expectancy and the 
sensitivity of developing tissues to the effects of 
radiation 
[5, 4, 11, 30, 31]
. 
Recently, there has been interest in CT techniques 
with low-dose radiations for the diagnosis of renal 
stones. By the improvement of scanner settings, the 
ionizing radiation dose delivered can be reduced by 50-
80% with minimal loss of diagnostic accuracy. While 
these modifications are appropriate for stone diagnosis, 
they may result in a reduced accuracy for other 
abdominal pathologies 
[1, 17, 26, 28, 31]
. 
Most stones can be imaged without the use of 
contrast agents. However, when obstruction is a 
concern, when non-opaque or low-density stones 
require careful delineation, or when details of urinary 
tract anatomy are needed, contrast agents are 
recommended. The most common ureteral calcification 
is a stone that has moved low from the kidney. These 
stones typically become impacted at narrowed 
anatomic sites and are especially difficult to be 
detected when they create altitude with bony structures 
such as the sacrum. The detection of a ureteral stone 
via ultrasonography is difficult 
[17]
. CT scan is better 
modality for its diagnosis 
[10, 17, 26, 28]
. 
Next, the color Doppler twinkling artifact can be 
used in all sides that are negative for stones in B mode 
ultrasonography. IVP is rarely indicated in patients 
with renal stone, but it can be helpful in some cases for 
determining the anatomy of calyces and pelvis before 
surgery. Some disadvantages of IVP in children with 
nephrolithiasis are radiation exposure, availability and 
the need to preparation 
[17, 18]
. 
Magnetic Resonance Impedance (MRI) and 
Magnetic Resonance urography (MRU) are unable to 
detect stones in urinary tract, but they can show an 
excellent view of urinary tract anatomy. The limitation 
of MRI and MRU is availability, cost–benefit issues 
and the need for preparation 
[31]
.  
 
 
Treatment: 
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The spontaneous stone passage is more common in 
children compared with adults. There are some medical 
and non-medical treatments for urolithiasis in children.  
 
 
Medical Treatment: 
Data on medical therapy of urolithiasis in pediatric 
patients are limited. There are very low numbers of 
trials focusing on the conservative treatment in children 
with varied metabolic types of renal stones. The main 
aims of medical therapy are to prevent further growth 
of existing stones and prevent the formation of new 
stones 
[43, 44]
. A high fluid intake is believed to be a key 
and universal treatment that is suggested for all types 
of stones. Other dietary considerations depend on the 
types of stones 
[44]
.  
 
 
Hypercalciuria: 
Hypercalciuria is one of the most common 
metabolic disorders in children with urolithiasis. In all 
children without available stone for analysis, the urine 
calcium concentration should be measured. The 
treatment aim is to reduce urinary calcium 
concentration as follows; 
 
 
1. Diet: 
The best initial management is increased fluid 
intake. However, the calcium intake restriction should 
not be recommended for a long time, because of 
increased risk of osteopenia, hyperoxaluria and then 
renal stone containing oxalate compounds. Adult’s 
studies have shown that low sodium and protein diets 
are more effective than low calcium diets in reducing 
urinary calcium concentration. In this respect, the first 
treatment of hypercalciruia is dietary changes including 
low protein and sodium diet, high potassium diet, 
avoidance excess calcium and vitamin D supplements 
and high fluid intake 
[44]
. 
 
 
2. Hydrochlorthiazide: 
Thiazide diuretics can be the choice of prescription 
(1-2 mg/kg/day) in patients with hypercalciuria. Some 
observational studies have shown a reduction in urine 
calcium concentration in those children treated with 
hydrochlorthiazide. Some guideline believes that 
thiazides are not efficient in children with 
hypercalciuria to reduce renal stone recurrence 
[44]
.  
There is some evidence that in patients with 
idiopathic hypercalciuria and recurrent stones, adding 
thiazides to a normal or modified diet reduces the 
number of stone recurrences and decreases the rate of 
stone formation. Thiazides and neutral potassium 
phosphate drugs could decrease hypercalciuria in 
symptomatic patients 
[41]
. 
 
 
3. Citrate potassium: 
Citrate potassium therapy is suggested in patients 
with chronic hypercalciuria. It is also useful in patients 
who have hypocitraturia and hypercalciuria 
concurrently. In this regard, the starting dose of citrate 
potassium is 1-2 meq/kg/day divided in two doses.  
No study is available regarding the comparison 
between citrate and thiazide diuretics in hypercalciuric 
patients. Also, no prospective studies have been 
performed on medical therapy for stone prevention in 
children with hypercaciuria 
[44, 45]
. Thiazides plus 
potassium salts significantly decrease calciuria and 
vitamin D levels 
[41]
. 
 
 
Hyperoxaluria: 
The goal of treatment of hyperoxaluria is to reduce 
oxalate production and increase its urinary solubility. 
The suggested treatments are high fluid intake, 
pyridoxine, low oxalate diet, regular calcium intake 
and medications such as calcium oxalate deposition 
inhibitors. 
It is believed that the restriction of diet oxalate has 
a limited effect on such patients. Pyridoxine can reduce 
the urinary oxalate concentration and may be useful in 
10-30% of patients with primary hyperoxaluria. The 
response to an initial pyridoxine dose (5-10 mg/kg/day) 
as test dose is defined as 30% reduction in urine 
oxalate after treatment 
[41, 45]
.  
Citrate potassium and neutral phosphate compound 
can be used in these patients. 
 
 
Cystinuria: 
The aim of treatment in cystinuria is to decrease 
cystin saturation in urine and to increase its solubility. 
High fluid intake, low salt diet, urine alkalization and 
the use of chelators are suggested. The restriction of 
methionine intake is not suggested by most researchers 
in the field of pediatric.  
Cystine chelators such as Mercaptopropionil 
glycine or tiopronine, D-penicillamine and/or captopril 
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are suggested when preliminary citrate and high fluid 
therapy fail to treat patients. It is believed that the 
maximal urinary cystine concentration is found during 
night, thus the night time treatment such as fluid intake 
and chelating therapy at bedtime is important. The aim 
is to reach urine PH to 7.5-8, and specific gravity less 
than 1010 
[16, 41]
.  
 
 
Hyperuricosuria: 
Uric acid stone formation depends on not only 
hyperuricosuria, but also the level of acidic urine. Thus 
the most important treatment for these patients is 
alkalization of urine by citrate therapy.  
 
 
Medical explosive therapy:  
This therapy includes the drugs that expel ureteral 
stones by relaxing smooth muscle.  
Calcium channel and alpha-1 receptors blockers are 
the main prescribed drugs. In some guidelines, this 
therapy is not recommended, because of little data in 
pediatric age group. Some clinicians administer alpha 
blocker medications in children with distal ureteral 
stone 
[1, 41]
.  
 
 
Extracorporeal Shock Wave Lithotripsy 
(ESWL): 
Currently, Extracorporeal Shock Wave Lithotripsy 
(ESWL) can be performed in children without long 
term kidney damage. The success of ESWL depends on 
some factors such as the type, size and location of 
stone. ESWL may be less efficient in cases of cystine 
stone, calcium monohydrate stones and the presence of 
anatomical abnormalities. It appears that the response 
to ESWL in children is higher than in adults even for 
large and staghorn stones. Although the available data 
about ESWL in children is insufficient, it appears that 
the percutaneous ESWL is safe and effective in this age 
group 
[22, 46, 47]
.  
For all children, the indications of ESWL are 
identical to those in adults. In this regard, renal stones 
with a diameter up to 20 mm are ideal for ESWL. On 
the other hand, ESWL is more effective for upper 
ureteral calculi in comparison with ureteroscopy. The 
PCNL is suggested as the first choice modality to treat 
staghorn and large size stones in children and it seems 
that the combination of PCNL and ESWL may be 
useful. 
After ESWL, the administration of citrate 
potassium is suggested to prevent stone regrowth and 
new stone formation in long run 
[22, 48, 49]
. 
 
 
Uretereoscopic lithotripsy: 
Both uretereoscopic lithotripsy and ESWL are 
effective modalities to treat ureteral stones. The 
selection of these modalities depends on the available 
equipment, expertise of surgeons, child’s age, urinary 
tract anatomy and the location of stone. ESWL is 
recommended in small children. Ureteroscopy is useful 
for middle and distal ureter stones 
[16, 23, 46, 47]
. 
 
 
Surgery Treatment: 
PCNL is a less invasive treatment compared with 
open surgery. Therefore, this technique is a useful 
alternative to open surgery in children. The indications 
of PCNL are similar in children and adults. PCNL is 
indicated in renal stones with a diameter more than 20 
mm. 
Most pediatric urinary tract stones are removed by 
ESWL, ureteroscopy and PCNL and a low number of 
stones are removed by open surgery. The indication of 
open surgery is the presence of large stones especially 
in small children and very obese children and those 
with malformation 
[41, 50, 51]
. 
 
 
Conclusions: 
The incidence of nephrolithiasis in children is 
increasing, yet few studies have assessed whether 
approach, diagnosis and dietary or pharmacological 
interventions decrease the recurrence of kidney stones 
in children. The clinical manifestation and evaluation 
of nephrolithiasis in children is different from those in 
adults. Imaging must be undertaken with care to 
identify stones, while avoiding excess radiation 
exposure. Because of the prevalence of metabolic risk 
factors and the significant risk of recurrence in this 
population, all children require a metabolic workup 
[18]
.  
Hence, thorough and early diagnostic examination 
is mandatory, for every patient with the first stone 
event. Following this advice, the recurrence of stone 
disease can be prevented. We reviewed the current 
literature on this topic, but further clinical trials are 
needed to determine the increasing prevalence, efficacy 
and effectiveness of different treatment modalities in 
children with nephrolithiasis. Additional areas in need 
of study are the optimal length of time for a trial of 
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stone passage in children, the cost-effectiveness of 
medical therapy, and the size and location of stones for 
which different therapies are most effective 
[5, 17, 18]
.  
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